0002005494-24-000003.txt : 20240412 0002005494-24-000003.hdr.sgml : 20240412 20240412101729 ACCESSION NUMBER: 0002005494-24-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 EFFECTIVENESS DATE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alger Life Sciences Innovation Fund LP CENTRAL INDEX KEY: 0001923614 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-442344 FILM NUMBER: 24840275 BUSINESS ADDRESS: STREET 1: 100 PEARL STREET, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 212-806-8800 MAIL ADDRESS: STREET 1: 100 PEARL STREET, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 D/A 1 primary_doc.xml X0708 D/A LIVE 0001923614 Alger Life Sciences Innovation Fund LP 100 PEARL STREET 27TH FLOOR NEW YORK NY NEW YORK 10004 212-806-8800 DELAWARE None None Limited Partnership true 2022 N/A Alger Alternative Holdings II, LLC 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Promoter General Partner of the Issuer N/A Fred Alger Management, LLC 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Promoter Investment Manager of the Issuer Daniel Cayley Chung 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Hal Liebes 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Robert Louis Kincel 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001923614-23-000001 2022-05-20 true true false 500000 Indefinite 23718260 Indefinite Clarification of Item 11: The minimum initial investment amount is $500,000, and the minimum additional investment amount is $250,000, which may be reduced or waived by the General Partner in its sole discretion. false 19 0 0 0 The Investment Manager will receive a management fee as outlined in the Issuer's offering material. false Alger Life Sciences Innovation Fund LP Hal Liebes Hal Liebes COO of Sole Member of GP of Issuer 2024-04-12